‘Huge Year’ for HER2+ Breast Cancer: Incorporating New Treatments
Drs Kathy Miller and Sara Hurvitz reflect on some of the trial results, including HER2CLIMB and DESTINY-Breast01, presented at this year’s SABCS that may ‘take your breath away.’
Related Articles
Dr Fernado Lopez-Rios – Biomarker Testing in Precision Oncology
Log in to save activities Your saved activities will show here so that you can easily access them whenever you’re ready. Log in here CME…
A Guideline-based Care Model for Endometrial Cancer in the Adjuvant Setting
Join these gynecologic oncology experts in a live social media event to hear the latest endometrial cancer clinical practice guidelines and key studies that …
Prostate Cancer Highlights: Expert Review of European Oncology Meeting
In this CME-accredited, live, and interactive social media event, a panel of 3 oncology experts will review key emerging prostate cancer data released at the…
BTK Inhibitors for Chronic Lymphocytic Leukemia: Pharmacist Viewpoints
Join us for a CPE-certified live social media event, providing instant engagement with top pharmacy experts in chronic lymphocytic leukemia (CLL) management….
Prostate Cancer Highlights: Expert Review of European Oncology Meeting
In this CME-accredited, live, and interactive social media event, a panel of 3 oncology experts will review key emerging prostate cancer data released at the…
A Guideline-based Care Model for Endometrial Cancer in the Adjuvant Setting
Join these gynecologic oncology experts in a live social media event to hear the latest endometrial cancer clinical practice guidelines and key studies that …